Ophthalmology Times

Lineage launches preclinical COR1 program for corneal endothelial disease

Lineage’s COR1 targets restoration of endothelial pump function via intracameral delivery and adhesion to Descemet membrane, ...
PharmiWeb

Lineage Launches New Cell Therapy Program in Corneal Endothelial Disease

Owned Asset Benefits From Existing Ophthalmology and Manufacturing ExpertiseFuchs Endothelial Corneal Dystrophy (FECD) ...
Healio

Q&A: First-ever allogeneic cell therapy to treat corneal endothelial disease approved

Please provide your email address to receive an email when new articles are posted on . Vyznova received regulatory approval in Japan for the treatment of bullous keratopathy. Injectable endothelial ...
Healio

FDA grants orphan drug designation for bullous keratopathy cell therapy

Please provide your email address to receive an email when new articles are posted on . The FDA has granted orphan drug designation for Cellusion’s CLS001 cell therapy. CLS001 is a corneal endothelial ...